Both gene sets are significantly enriched for the “Cell Death Of Tumour Cell Lines” pathway (p-value = 1.1e-4 for GS-IFN and p-value = 5.64e-3 for GS-COM): 19 genes are specifically upregulated upon IFNγ treatment (CASP4, CASP7, CLEC2D, DDX58, ENC1, FST, GDNF, IL15RA, IL7, IRAK2, IRF1, LGALS3BP, MLKL, SOCS3, STAT2, STAT3, TRIM21, UACA, UBA7). The gene discussed is MLKL; the disease is neoplasm.